$ANOD B #AddNode Group ... Talking Points - Oncopeptides (Buy): FDA filing coming up: Veidekke (Buy) Preview of results: Look beyond the short-term uncertainty We compare timelines with XPOVIO (selinexor) Reiterate BUY for our top pick in… https://t.co/nPG4cMxMZ1 #equity #stocks